Replication and Inhibitors of Enteroviruses and Parechoviruses

The Enterovirus (EV) and Parechovirus genera of the picornavirus family include many important human pathogens, including poliovirus, rhinovirus, EV-A71, EV-D68, and human parechoviruses (HPeV). They cause a wide variety of diseases, ranging from a simple common cold to life-threatening diseases suc...

Full description

Bibliographic Details
Main Authors: Lonneke van der Linden, Katja C. Wolthers, Frank J.M. van Kuppeveld
Format: Article
Language:English
Published: MDPI AG 2015-08-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/7/8/2832
id doaj-8a8279d67d244649811bc4654ca4dfb6
record_format Article
spelling doaj-8a8279d67d244649811bc4654ca4dfb62020-11-24T22:35:00ZengMDPI AGViruses1999-49152015-08-01784529456210.3390/v7082832v7082832Replication and Inhibitors of Enteroviruses and ParechovirusesLonneke van der Linden0Katja C. Wolthers1Frank J.M. van Kuppeveld2Laboratory of Clinical Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, Amsterdam 1105 AZ, The NetherlandsLaboratory of Clinical Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, Amsterdam 1105 AZ, The NetherlandsVirology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, Utrecht 3584 CL, The NetherlandsThe Enterovirus (EV) and Parechovirus genera of the picornavirus family include many important human pathogens, including poliovirus, rhinovirus, EV-A71, EV-D68, and human parechoviruses (HPeV). They cause a wide variety of diseases, ranging from a simple common cold to life-threatening diseases such as encephalitis and myocarditis. At the moment, no antiviral therapy is available against these viruses and it is not feasible to develop vaccines against all EVs and HPeVs due to the great number of serotypes. Therefore, a lot of effort is being invested in the development of antiviral drugs. Both viral proteins and host proteins essential for virus replication can be used as targets for virus inhibitors. As such, a good understanding of the complex process of virus replication is pivotal in the design of antiviral strategies goes hand in hand with a good understanding of the complex process of virus replication. In this review, we will give an overview of the current state of knowledge of EV and HPeV replication and how this can be inhibited by small-molecule inhibitors.http://www.mdpi.com/1999-4915/7/8/2832enterovirushuman parechovirusreplicationantiviralsmall moleculesinhibitor
collection DOAJ
language English
format Article
sources DOAJ
author Lonneke van der Linden
Katja C. Wolthers
Frank J.M. van Kuppeveld
spellingShingle Lonneke van der Linden
Katja C. Wolthers
Frank J.M. van Kuppeveld
Replication and Inhibitors of Enteroviruses and Parechoviruses
Viruses
enterovirus
human parechovirus
replication
antiviral
small molecules
inhibitor
author_facet Lonneke van der Linden
Katja C. Wolthers
Frank J.M. van Kuppeveld
author_sort Lonneke van der Linden
title Replication and Inhibitors of Enteroviruses and Parechoviruses
title_short Replication and Inhibitors of Enteroviruses and Parechoviruses
title_full Replication and Inhibitors of Enteroviruses and Parechoviruses
title_fullStr Replication and Inhibitors of Enteroviruses and Parechoviruses
title_full_unstemmed Replication and Inhibitors of Enteroviruses and Parechoviruses
title_sort replication and inhibitors of enteroviruses and parechoviruses
publisher MDPI AG
series Viruses
issn 1999-4915
publishDate 2015-08-01
description The Enterovirus (EV) and Parechovirus genera of the picornavirus family include many important human pathogens, including poliovirus, rhinovirus, EV-A71, EV-D68, and human parechoviruses (HPeV). They cause a wide variety of diseases, ranging from a simple common cold to life-threatening diseases such as encephalitis and myocarditis. At the moment, no antiviral therapy is available against these viruses and it is not feasible to develop vaccines against all EVs and HPeVs due to the great number of serotypes. Therefore, a lot of effort is being invested in the development of antiviral drugs. Both viral proteins and host proteins essential for virus replication can be used as targets for virus inhibitors. As such, a good understanding of the complex process of virus replication is pivotal in the design of antiviral strategies goes hand in hand with a good understanding of the complex process of virus replication. In this review, we will give an overview of the current state of knowledge of EV and HPeV replication and how this can be inhibited by small-molecule inhibitors.
topic enterovirus
human parechovirus
replication
antiviral
small molecules
inhibitor
url http://www.mdpi.com/1999-4915/7/8/2832
work_keys_str_mv AT lonnekevanderlinden replicationandinhibitorsofenterovirusesandparechoviruses
AT katjacwolthers replicationandinhibitorsofenterovirusesandparechoviruses
AT frankjmvankuppeveld replicationandinhibitorsofenterovirusesandparechoviruses
_version_ 1725725390761099264